These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6821030)

  • 21. [African aspects of vaccination in prevention of purulent meningitis].
    Rey M
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
    [No Abstract]   [Full Text] [Related]  

  • 22. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
    McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
    J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary: prophylaxis for contacts of patients with meningococcal disease.
    Gold R
    Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315
    [No Abstract]   [Full Text] [Related]  

  • 25. Status of a group B Neisseria meningitidis vaccine.
    Frasch CE
    Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of meningococcal polysaccharide vaccine serogroup "A" (Pilot Study).
    Bahl MR
    Med J Zambia; 1975 Dec-1976 Jan; 9(6):166. PubMed ID: 818845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
    Zhao JW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
    [No Abstract]   [Full Text] [Related]  

  • 28. [The new meningococcal vaccines].
    Triau R
    Nouv Presse Med; 1974 Oct; 3(36):2325-8. PubMed ID: 4218314
    [No Abstract]   [Full Text] [Related]  

  • 29. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in epidemic features of epidemic cerebrospinal meningitis after vaccination with purified meningococcal polysaccharide vaccine group A in Zhengzhou].
    Wiu JJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 May; 27(3):160-1. PubMed ID: 8243180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A controlled trial with 2 anti-Neisseria B meningitidis vaccines and placebo in Chilean population].
    Herrera P; Lagos R
    Rev Med Chil; 1998 Nov; 126(11):1403-4. PubMed ID: 10349187
    [No Abstract]   [Full Text] [Related]  

  • 32. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
    Chippaux JP; Debois H; Saliou P
    Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of epidemic meningococcal meningitis by mass vaccination.
    Mohammed I; Zaruba K
    Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.
    De Wals P; Dionne M; Douville-Fradet M; Boulianne N; Drapeau J; De Serres G
    Bull World Health Organ; 1996; 74(4):407-11. PubMed ID: 8823963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serogroup A N. meningitidis polysaccharide vaccine and serogroup A N. meningitidis carrier state (author's transl)].
    Bencić Z; Madarić D; Manhalter T; John V; Amsel V; Weisglass H
    Lijec Vjesn; 1978 Nov; 100(11):706-7. PubMed ID: 107385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.